367
Views
175
CrossRef citations to date
0
Altmetric
Research Article

Dependence, Tolerance, and Addiction to Benzodiazepines: Clinical and Pharmacokinetic Considerations

&
Pages 13-28 | Published online: 22 Sep 2008

References

  • Greenblatt D. J., Shader R. I., Koch-Weser J. “Psychotropic Drug Use in the Boston Area: A Report from the Boston Collaborative Drug Surveillance Program,”. Arch. Gen. Psychiatry 1975; 32: 518–521
  • Baiter M. B., Levine J., Manheimer D. I. “Cross-National Study of the Extent of Antianxiety/Sedative Drug Use,”. N. Engl. J. Med. 1974; 290: 769–774
  • Isbell H. “Clinical Aspects of the Various Forms of Nonmedical Use of Drugs,”. Anesth. Analg. (Cleveland) 1971; 50: 886–905
  • Kalant H., Le Blanc A. E., Gibbins R. J. “Tolerance to, and Dependence on, Some Nonopiate Psychotropic Drugs,”. Pharmacol. Rev. 1971; 23: 135–191
  • Wikler A. “Dynamics of Drug Dependence: Implications of a Conditioning Theory for Research and Treatment,”. Arch. Gen. Psychiatry 1973; 28: 611–616
  • Hollister L. E., Motzenbecker F. P., Degan R. O. “Withdrawal Reactions from Chlordiazepoxide (Librium),”. Psychopharmacologia 1961; 2: 63–68
  • Barten H. H. “Toxic Psychosis with Transient Dysmnestic Syndrome Following Withdrawal from Valium.”. Am. J. Psychiatry 1965; 121: 1210–1211
  • Clare A. W. “Diazepam, Alcohol, and Barbiturate Abuse,”. Br. Med. J. 1971; 4: 340
  • Darcy L. “Delirium Tremens Following Withdrawal of Nitrazepam,”. Med. J. Aust 1972; 2: 450
  • Gordon E. B. “Addiction to Diazepam (Valium),”. Br. Med. J. 1967; 1: 112
  • Guile L. A. “Rapid Habituation to Chlordiazepoxide (Librium),”. Med. J. Aust 1963; 2: 56–57
  • Hanna S. M. “A Case of Oxazepam (Serenid D) Dependence,”. Br. J. Psychiatry 1972; 120: 443–445
  • Relkin R. “Death Following Withdrawal of Diazepam,”. N.Y. State J. Med. 1966; 66: 1770–1772
  • Selig J. W. “A Possible Oxazepam Abstinence Syndrome,”. J. Am. Med. Assoc 1966; 198: 951–952
  • Slater J. “Suspected Dependence on Chlordiazepoxide Hydrochloride (Librium),”. Can. Med. Assoc. J. 1966; 95: 416
  • Fruensgaard K. “Withdrawal Psychosis: A Study of 30 Consecutive Cases,”. Acta Psychiatr. Scand 1976; 53: 105–118
  • Haskell D. “Withdrawal of Diazepam,”. J. Am. Med. Assoc 1975; 233: 135
  • Preskorn S. H., Denner L. J. “Benzodiazepines and Withdrawal Psychosis,”. J. Am. Med. Assoc 1977; 237: 36–38
  • Floyd J. B., Jr., Murphy C. M. “Hallucinations Following Withdrawal of Valium,”. J. Ky. Med. Assoc 1976; 74: 549–550
  • Rifkin A., Quitkin F., Klein D. F. “Withdrawal Reaction to Diazepam,”. J. Am. Med. Assoc 1976; 236: 2172–2173
  • Misra P. C. “Nitrazepam (Mogadon) Dependence,”. Br. J. Psychiatry 1975; 126: 81–82
  • Woody G. E., O'Brien C. P., Greenstein R. “Misuse and Abuse of Diazepam: An Increasingly Common Medical Problem,”. Int. J. Addict 1975; 10: 843–848
  • Rementeria J. L., Bhatt K. “Withdrawal Symptoms in Neonates from Intrauterine Exposure to Diazepam,”. J. Pediatr 1977; 90: 123–126
  • Athinarayanan P., Pierog S. H., Nigam S. K., Glass L. “Chlordiazepoxide Withdrawal in the Neonate,”. Am. J. Obstet. Gynecol 1976; 124: 212–213
  • Greenblatt D. J., Shader R. I., Koch-Weser J. “Pharmacokinetics in Clinical Medicine: Oxazepam Versus Other Benzodiazepines,”. Dis. Nerv. Syst 1975; 36: 6–13, (5, Sec 2)
  • Greenblatt D. J., Shader R. I. “Benzodiazepines,”. N. Engl. J. Med. 1974; 291: 1011–1015; 1239–1243
  • Hollister L. E. “Valium: A Discussion of Current Issues,”. Psychosomatics 1977; 18: 44–58
  • Covi L., Park L. C., Lipman R. S., Uhlenhuth E. H., Rickels K. “Factors Affecting Withdrawal Response to Certain Minor Tranquilizers,”. Drug Abuse: Social and Psycho-pharmacological Aspects, J. O. Cole, J. R. Wittenborn. Thomas, Springfield, Illinois 1969; 93–108
  • Covi L., Lipman R. S., Pattison J. H., Derogatis L. R., Uhlenhuth E. H. “Length of Treatment with Anxiolytic Sedatives and Response to Their Sudden Withdrawal,”. Acta Psychiatr. Scand 1973; 49: 51–64
  • Hollister L. E. “Withdrawal from Benzodiazepine Therapy,”. J. Am. Med. Assoc 1977; 237: 1432
  • Winstead D. K., Anderson A., Eilers M. K., Blackwell B., Zaremba A. L. “Diazepam on Demand: Drug-Seeking Behavior in Psychiatric Inpatients,”. Arch. Gen. Psychiatry 1974; 30: 349–351
  • Hubbard B., Kripke D. F. “Hypnotic and Minor Tranquilizer Use among Inpatients and after Discharge,”. Int. J. Addict 1976; 11: 403–408
  • Patch V. D. “The Dangers of Diazepam, a Street Drug,”. N. Engl. J. Med. 1974; 290: 807
  • Woody G. E., Mintz J., O'Hare K. C., O'Brien P., Greenstein R. A., Hargrove E. “Diazepam Use by Patients in a Methadone Program–How Serious a Problem?”. J. Psychedelic Drugs 1975; 7: 373–379
  • Adam K., Adamson L., Brezinova V., Hunter W. M., Oswald I. “Nitrazepam: Lastingly Effective but Trouble on Withdrawal,”. Br. Med. J. 1976; 1: 1558–1560
  • Greenblatt D. J., Shader R. I., Harmatz J. S., Franke K., Koch-Weser J. “Absorption Rate, Blood Concentrations, and Early Responses to Oral Chlordiazepoxide,”. Am. J. Psychiatry 1977; 134: 559–562
  • MacLeod S. M., Giles H. G., Patzalek G., Thiessen J. J., Sellers E. M. “Diazepam Actions and Plasma Concentrations Following Ethanol Ingestion,”. Eur. J. Clin. Pharmacol., U 1977; 345–349
  • Bliding A. “Effects of Different Rates of Absorption of Two Benzodiazepins on Subjective and Objective Parameters,”. Eur. J. Clin. Pharmacol 1974; 7: 201–211
  • Hillestad L., Hansen T., Melsom H. “Diazepam Metabolism in Normal Man. II. Serum Concentrations and Clinical Effect after Oral Administration and Cumulation,”. Clin. Pharmacol. Ther 1974; 16: 485–489
  • Kaplan S. A., Jack M. L., Alexander K., Weinfeld R. E. “Pharmacokinetic Profile of Diazepam in Man Following Single Intravenous and Oral and Chronic Oral Administration,”. J. Pharm. Sci. 1973; 62: 1789–1796
  • Gamble J. A. S., Dundee J. W., Gray R. C. “Plasma Diazepam Concentrations Following Prolonged Administration,”. Br. J. Anaesth 1976; 48: 1087–1090
  • Eatman F. B., Colburn W. A., Boxenbaum H. G., Posmanter H. H., Weinfeld R. E., Ronfeld R., Weissman L., Moore J. D., Gibaldi M., Kaplan S. A. “Pharmacokinetics of Diazepam Following Multiple-Dose Oral Administration to Healthy Human Subjects,”. J. Pharmacokinet. Biopharm 1977; 5: 481–494
  • Kaplan S. A.J., deSilva A. F., Jack M. L., Alexander K., Strojny N., Weinfeld R. E., Puglisi C. V., Weissman L. “Blood Level Profile in Man Following Chronic Oral Administration of Flurazepam Hydrochloride,”. J. Pharm. Sci. 1973; 62: 1932–1935
  • Greenblatt D. J., Shader R. I., Koch-Weser J. “Flurazepam Hydrochloride,”. Clin. Pharmacol. Ther 1975; 17: 1–14
  • Greenblatt D. J., Shader R. I., Koch-Weser J. “Flurazepam Hydrochloride, A Benzodiazepine Hypnotic,”. Ann. Intern. Med. 1975; 83: 237–241
  • Cannizzaro G., Nigito S., Provenzano P. M., Vitikova T. “Modification of Depressant and Disinhibitory Action of Flurazepam during Short Term Treatment in the Rat,”. Psycho-pharmacologia 1972; J26: 173–184
  • Stein L., Berger B. D. “Psychopharmacology of 7-Chloro-5-(o-chlorophenyl)-1, 3-dihydro-3-hydroxy-2H-1, 4-benzodi-azepin-2-one (Lorazepam) in Squirrel Monkey and Rat,”. Arzneim.-Forsch 1971; 21: 1073–1078
  • Margules D. L., Stein L. “Increase of Antianxiety Activity and Tolerance of Behavioral Depression during Chronic Administration of Oxazepam,”. Psychopharmacologia 1968; 13: 74–80
  • Matsuki K., Iwamoto T. “Development of Tolerance to Tranquilizers in the Rat,”. Jpn. J. Pharmacol 1966; 16: 191–197
  • Greenblatt D. J., Shader R. I. Benzodiazepines in Clinical Practice. Raven, New York 1974; 242–249
  • Vesell E. S., Passananti G. T., Viau J. P., Epps J. E., Di Carlo F. J. “Effects of Chronic Prazepam Administration on Drug Metabolism in Man and Rat,”. Pharmacology, T 1972; 197–206
  • Klotz U., Antonin K. H., Bieck P. R. “Comparison of the Pharmacokinetics of Diazepam after Single and Subchronic Doses,”. Eur. J. Clin. Pharmacol 1976; 10: 121–126
  • Kanto J., Iisalo E., Lehtinen V., Salminen J. “The Concentrations of Dia zepam and Its Metabolites in the Plasma after an Acute and Chronic Administration,”. Psychopharmacologia 1974; 36: 123–131
  • Sellman R., Kanto J., Raijola E., Pekkarinen A. “Induction Effect of Diazepam on Its Own Metabolism,”. Acta. Phar-macol. Toxicol 1975; 37: 345–351
  • Boston Collaborative Drug Surveillance Program. “Clinical Depression of the Central Nervous System Due to Diazepam and Chloriazepoxide in Relation to Cigarette Smoking and Age,”. N. Engl. J. Med. 1973; 288: 277–280
  • Klotz U., Avant G. R., Hoyumpa A., Schenker S., Wilkinson G. R. “The Effects of Age and Liver Disease on the Disposition and Elimination of Diazepam in Adult Man,”. J. Clin. Invest 1975; 55: 347–359

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.